Houston ranks No. 3 on list of cities with the most people in financial distress amid COVID-19

money problems

Out of the largest 100 cities in the country, Houston ranks high up on the list that evaluated personal financial distress of citizens. Photo by Scott Halleran/Getty Images

During the pandemic-produced recession, debt and loans are weighing heavily on the hearts and minds of Houstonians.

A study released this week by personal finance website WalletHub found Houston ranks first among the country's 100 largest United States cities for online searches about debt and first for online searches about loans. Overall, Houston ranks third for financial distress, behind first-place Las Vegas and second-place Chicago.

To examine where Americans are struggling the most financially, WalletHub compared the 100 largest cities across nine key metrics. Factors taken into consideration include average credit score, number of bankruptcy filings between June 2020 and June 2019, and online searches regarding debt and loans.

Aside from sitting at No. 1 for interest in debt and loans, Houston ranks:

  • No. 9 for share of people with accounts in distress in September
  • No. 9 for average number of accounts in distress in September
  • No. 12 for average credit score in September

WalletHub defines a distressed account as one for which payments have been reduced, skipped or delayed.

Among Texas cities, Houston has a lot of company in WalletHub's top 10. San Antonio appears at No. 4, Dallas at No. 5, Austin at No. 8, and Fort Worth at No. 10. In all, the ranking includes 13 Texas cities. Irving demonstrates the most financial stability of the 13 cities, according to WalletHub, with its financial stress ranking at No. 72.

As with almost every U.S. city, Houston has been whacked by the recession. In September, the metro area's unemployment rate stood at 9.6 percent, up from 8.1 percent the previous month. Compared with the state's three other major metro areas, Houston's September unemployment rate was the highest. The September jobless rate was 6.4 percent in Austin, 7.4 percent in Dallas, 7.6 percent in Fort Worth, and 7.8 percent in San Antonio. The statewide unemployment rate was 8.3 percent, while the nationwide unemployment rate was 7.7 percent.

One of the main drivers of Houston's high unemployment rate is the ongoing slump in the U.S. oil, gas, and chemical industry. A report released October 5 by consulting giant Deloitte showed the nationwide sector shed 107,000 jobs from March to August.

"We will never see oil and gas employment get back to where it was in December 2014. Employment in the industry today is pretty much where it was in 2006," Patrick Jankowski, senior vice president of research at the Houston Partnership, said in June. "Energy has been real good to Houston. It's still a big part of our economy, but we cannot rely on it like we have in the past."

A September report from the Federal Reserve Bank of Dallas noted that the Houston area is in recovery mode, but the pace has slowed, mostly due to weakness in the energy sector. The report says "that while Houston's recovery is likely to continue, it will lag the state."

The report adds that the Houston area had recovered 33 percent of pandemic-era job losses as of August, compared with 42 percent across Texas and 48 percent nationwide.

Of course, the pandemic recession also has hammered the hospitality industry.

During his State of the City address on October 22, Houston Mayor Sylvester Turner said said 196 meetings, conferences, and conventions in the city had been canceled or rescheduled since March. The result: an estimated economic loss of $332 million. The city's hotel occupancy rate stands at a meager 44 percent, according to Turner, with the rate for downtown hotels at only 17 percent.

The pandemic's impact during the rest of 2020 and into 2020 "will be significant for our hospitality community," the mayor said.

Despite the downturn in the energy and hospitality sectors, Turner and others feel optimistic about what's ahead for Houston.

"As we gradually take steps to reopen, we recognize that the full recovery will take several years, but when we work together, we put ourselves in the best position to manage the virus and rebound from it," Turner said. "As we move forward through these unprecedented times, the city's foundation is strong, the city itself is resilient, and the city's future is bright."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

View All Listings